Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: cryopreservation.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D002470:Cell Survival; D002478:Cells, Cultured; D003094:Collagen / Q000494:pharmacology*; D015925:Cryopreservation; D020405:Dermis / Q000254:growth & development / Q000648:ultrastructure; D004337:Drug Carriers; D005347:Fibroblasts / Q000166:cytology* / Q000378:metabolism; D006801:Humans; D006820:Hyaluronic Acid / Q000494:pharmacology*; D017768:Skin, Artificial; D014184:Transplantation, Homologous; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D000276:Adjuvants, Immunologic; D004337:Drug Carriers; D042461:Vascular Endothelial Growth Factor A; C059821:atelocollagen; D006820:Hyaluronic Acid; D003094:Collagen